The RAD51C gene helps repair breaks in DNA, which protects cells as they grow and divide. This gene plays an important role in keeping the genetic instructions stable. If it does not work well, DNA damage can build up and raise the chance of certain cancers, especially ovarian cancer and sometimes breast cancer. People with two nonworking copies can develop a rare inherited condition called Fanconi anemia, which may affect growth, blood cells, and cancer risk.
What is a gene?
Genes are pieces of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, which do much of the work inside cells. Others mainly guide when certain processes happen, where they take place, and how strongly they run. Together, genes affect how the body develops and functions, and they can shape how you respond to food, stress, or medications. More information about this topic is available in the LearnHub.
Overview
RAD51CGene function
What if the gene works
The RAD51C gene helps cells repair broken DNA. This supports stable chromosomes and healthy cell division. It also works with related repair proteins to help protect the ovaries and other tissues over time.
Risk
What if the gene does not work
Variants in the RAD51C gene can raise the risk of ovarian and breast cancer. Rare, more severe variants affecting both copies can cause a Fanconi anemia condition with bone marrow problems, developmental differences, and childhood cancer risk.
Treatment
What does that mean for your treatment
Pathogenic variants in the RAD51C gene can support use of PARP inhibitor treatment in some settings, especially metastatic castration-resistant prostate cancer, where current guidelines include RAD51C among repair genes that may guide drug choice. In ovarian cancer, RAD51C loss may contribute to homologous recombination deficiency (reduced DNA repair ability), which can affect PARP inhibitor use, although decisions are usually based on the broader tumor profile rather than RAD51C alone.
Conditions associated with RAD51C
Gene function
What if the gene works
Your cells constantly need to copy and protect their DNA as they grow and divide. The RAD51C gene supports careful DNA upkeep, especially when a DNA strand breaks and the cell needs an accurate fix. This steady repair work helps cells keep the right genetic information over time.
One of the main jobs of the RAD51C gene is to help fix breaks in DNA. It helps the cell use an intact matching DNA copy as a guide, which supports a more accurate repair.
Inside your cells, the RAD51C gene works with a small group of partner proteins during DNA repair. Together they organize repair steps so the broken area can be checked, lined up, and rebuilt in a controlled way.
By helping with broken DNA and careful rebuilding, the RAD51C gene supports chromosome stability during cell growth and division. Understanding how the RAD51C gene helps repair damaged DNA makes it easier to see why this role matters every day.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human differences, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the RAD51C gene can weaken how cells repair broken DNA, especially through a precise repair process used for major DNA damage. Some variants slightly change the protein’s shape or its ability to work with partner proteins, while more disruptive variants can leave the protein shortened, unstable, or missing. This range helps explain how RAD51C variants affect gene function, and why stronger loss of function is often linked to a greater effect on cancer risk.
How variants are linked to conditions
Pathogenic variants in the RAD51C gene are linked to inherited breast and ovarian cancer risk, with the clearest association seen for ovarian cancer and a smaller increase in breast cancer risk in some people. These variants do not mean cancer is certain, but they can help explain why cancer runs in a family. Rarely, pathogenic variants in both copies of the RAD51C gene cause a form of Fanconi anemia, a condition that can involve low blood counts, growth differences, and a higher chance of some cancers.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct impact on health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental influences are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful change in the RAD51C gene, cancer risk is driven mainly by that inherited change, and it can be higher with a strong family history of breast or ovarian cancer. Risk also changes with age and sex, but there is not enough evidence to say that lifestyle changes clearly lower this inherited risk.
Inheritance of RAD51C variants
Inheritance of the RAD51C gene variants depends on the condition involved. For hereditary cancer risk linked to the RAD51C gene, the pattern is usually autosomal dominant, so a parent carrying a pathogenic variant can pass it to a child with a 50% chance in each pregnancy. When a person inherits two pathogenic RAD51C variants, one from each parent, this can cause a rare condition in the Fanconi anemia spectrum, which follows an autosomal recessive pattern. This mixed picture explains why the inheritance of the RAD51C gene variants is not described by a single pattern alone.
What does my RAD51C result mean for my family?
For many living with a harmful change in the RAD51C gene linked to hereditary breast and ovarian cancer risk, close blood relatives may also carry the same change and may want to learn whether it runs in the family. RAD51C can also be tied to a rare childhood condition when both copies of the gene are changed, so family meaning depends on which RAD51C result or condition is involved. A genetics expert can help sort out what that means for relatives.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the RAD51C gene, genetic testing uses a blood or saliva sample to read the gene's DNA code. RAD51C genetic testing looks for variants that may help explain inherited cancer risk and can show whether a specific family variant is present.
When should I consider getting a genetic test?
Consider RAD51C testing if you or close relatives have had ovarian cancer, especially at a younger age, or a strong family history of breast and ovarian cancer. Testing can also help if a family member already has a harmful RAD51C variant, because it may clarify your inherited cancer risk and screening needs.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at the target tissue. This helps explain why the same treatment works well for one person but less well for another, or why some people are more sensitive to side effects. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics explores how genetic differences can affect a person’s response to medicines. By looking at links between genes and medications, it helps explain why the same treatment may work differently from one person to another. For many drugs, genes can influence both how strongly a medicine works and how the body handles it. Understanding this can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in LearnHub.
Drugs influenced by the RAD51C gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding everyday medication choices, so general health or medicine concerns are best discussed with your doctor. RAD51C is mainly being studied in cancer care, where changes in a tumor may help doctors think about response to certain DNA-damaging treatments, but this is handled by an oncology team rather than routine prescribing.
History
RAD51C entered genetics research in the late 1990s, when scientists identified it as part of a group of human genes related to RAD51. From these first observations, research expanded steadily. In 2010, RAD51C drew wider attention when inherited variants were linked to some families with ovarian cancer and breast cancer, helping shape modern hereditary cancer testing. Around the same time, more disruptive variants in both copies of the gene were connected with a rare inherited condition within the Fanconi anemia spectrum, which broadened medical interest in RAD51C. These milestones placed RAD51C among the better known DNA repair genes studied in cancer genetics today.